Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study

ConclusionImplantation of a magnesium-based bioresorbable stent in patients with acute coronary syndrome is associated with a greater extent of late lumen loss at the 12-month follow-up compared with implantation of a permanent, everolimus-eluting metallic stent.Trial Registration: ISRCTN89434356

http://link.springer.com/10.1007/s10557-021-07258-z

Source: Cardiovascular Drugs and Therapy - September 10, 2021 Category: Cardiology Source Type: research